Who Owns REVBW?

Revelation Biosciences, Inc. Warrant — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

$60K

Shares Outstanding

Institutional Holders

9

Total Inst. Value

$11K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

9

Closed Positions

0

Increased

0

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1LINDEN ADVISORS LPNew$4K338,110
2Yakira Capital Management, Inc.New$3K246,884
3Tabor Asset Management, LPNew$3K246,884
4WOLVERINE ASSET MANAGEMENT LLCNew$59154,752
5JANE STREET GROUP, LLCNew$54050,000
6CITADEL ADVISORS LLCNew$36636,568
7POM Investment Strategies, LLCNew$111,005
8UBS Group AGNew$3272
9HRT FINANCIAL LPNew$013,144

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold REVBW?

As of Q1 2025, 9 institutional investors report holding REVBW (Revelation Biosciences, Inc. Warrant) in their 13F filings.

Which hedge fund owns the most REVBW?

The largest institutional holder of REVBW is LINDEN ADVISORS LP with $4K in shares.

Are institutions buying or selling REVBW?

This quarter, 9 institutions opened new positions in REVBW and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.